VAC4EU Postauthorisation Effectiveness Study of BIMERVAX® Vaccine in Europe

21/10/2024
13/02/2026
EU PAS number:
EUPAS1000000337
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol_PAES_6578_HIPRA_BIMERVAX_v1.1_19Feb2024_Redacted.pdf

English (1.71 MB - PDF) View document
Updated protocol

Protocol_PAES_6578_HIPRA_BIMERVAX_v3.0_Final_31Oct2025_Redacted.pdf

First published: 12/02/2026
English (1.04 MB - PDF) View document

Protocol_PAES_6578_HIPRA_BIMERVAX_v2.0_12March2025_redacted.pdf

First published: 25/11/2025
English (1.01 MB - PDF) View document
Study results
Study report
Other information
ENCePP Seal
Conflicts of interest of investigators

01_DeclarationofInterests-Annex5 - signed.pdf

English (222.59 KB - PDF) View document
Composition of steering group and observers

02_ENCePPCoCSteeringGroup.pdf

English (43.37 KB - PDF) View document
Signed code of conduct

03_ENCePPCoCAnnex3_DeclarationofcompliancewiththeENCePPCodeofConduct - signed.pdf

English (161.23 KB - PDF) View document
Signed code of conduct checklist

04_ENCePPCoCAnnex2_ChecklistofCodeofConduct - signed.pdf

English (307.26 KB - PDF) View document
Signed checklist for study protocols

05_ENCePPChecklistforStudyProtocol - signed.pdf

English (515.48 KB - PDF) View document